Anticoagulants Market by Manufacturers, Regions, Type and Application Forecast to 2030 Anticoagulants Market report gives attention to market segmentation, market size, and forecast of 2022-2030 to help stakeholders in making a good decision for the future investments. Bioreactors industry report segmented into types, application, and regions with providing production, revenue, import/export. The COVID-19 pandemic has been instrumental in boosting the production of blood thinners as people suffering from cardiac ailments were at a higher risk of contracting the infection because of low immunity. Furthermore, major players in the industry have been focusing on expanding their production capacity and implementing strategies to fortify their market position. Browse key industry insights spread across 181 pages with 227 market data tables & 18 figures & charts from the report, “Anticoagulants Market Size By Drug Class (Factor Xa Inhibitors, Heparin, Warfarin, Direct Thrombin Inhibitors), By Route of Administration (Oral, Injectables), By Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/anticoagulants-market For instance, in December 2021, pharma giant Johnson & Johnson announced that the U.S. FDA had approved two of its pediatric indications for XARELTO. These drugs are designed for use in venous thromboembolism (VTE) treatment as well as to cut the risks of recurrent VTE in patients aged below 18 years. The anticoagulants market has been divided by route of administration, distribution channel, drug category, application, and region. Based on the drug category, the market has been bifurcated into factor Xa inhibitor, direct thrombin inhibitor, heparin, and warfarin (Vitamin K antagonist). Among these, the direct thrombin inhibitor segment accounted for more than 12.7% market share in 2021. These inhibitors function by slowing down the activity of the thrombin protein to delay the blood clotting process and are hence used to treat heparin-induced thrombocytopenia (HIT) and acute coronary syndrome. On the basis of route of administration, the anticoagulants market has been categorized into injectables and oral. The injectables segment is set to witness robust growth over 20222030 backed by rising usage of injectables in various disease treatments.
© 2022 All Rights Reserved
www.gminsights.com